Speakers from Coalition for Access Now, U.S.
Pain Foundation, Balanced Veterans Network, ToxStrategies LLC
and Dentons Advised Congress on CBD Regulation
LOUISVILLE, Colo., Dec. 7, 2023
/CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings,
Inc. ("Charlotte's Web" or the "Company"), the industry pioneer and
market leader in hemp-derived cannabidiol (CBD) wellness is pleased
to announce that CBD experts and advocates joined the ONE HEMP
coalition in Washington DC
yesterday to meet with members of Congress and their staff on
Capitol Hill.
"The message of today's briefing was clear – the supply chain
bottleneck caused by lack of regulation is negatively impacting
millions of CBD consumers, farmers and manufacturers. ONE HEMP has
provided sensible policy solutions backed by science to open a
pathway for a safe, standardized CBD industry. Today was a critical
step in our next goal to secure committee hearings with Energy
& Commerce and Senate HELP," said Jared Stanley, co-founder and Chief Commercial
Officer of Charlotte's Web.
During the briefing, Kelly D.
Fair, Strategic Advisor to ONE HEMP, Dentons U.S.
Cannabis and Hemp Group Partner, and organizer of ONE HEMP's RFI
submission, outlined the policy recommendations saying, "Policy
solutions must lead with science, address FDA concerns, protect
states' rights, and meet the market where it is. Retailers want to
sell CBD products and consumers want to access to them."
The panelists featured an authoritative, in-depth discussion on
the current regulatory status of CBD and the best path forward by
CBD industry experts and advocates including:
- Jennifer Baxter,
Executive Director, Balanced Veterans Network
- Kelly Fair, Strategic
Advisor, ONE HEMP and US Cannabis and Hemp Group Partner,
Dentons
- Paige Figi, Executive
Director, Coalition for Access Now
- Nicole Hemmenway, CEO,
U.S. Pain Foundation
- Dr. Rayetta Henderson,
Foods & Consumer Products, Senior Managing Scientist,
ToxStrategies LLC
The panelists spoke to the beneficial role that CBD plays in the
lives of millions of Americans from all walks of life, along with
key scientific and policy solutions for the future FDA regulation
of CBD products as dietary supplements.
LISTEN IN: To watch a recording of the meeting,
follow this link: 12-6-2023 ONE HEMP
DC Briefing
The ONE HEMP briefing was part of a broader effort to urge the
committees of jurisdiction in Congress – House Energy and Commerce
and Senate "HELP" – to move ahead with marking up legislation. The
nation's hemp and CBD producers, and the millions of Americans who
rely on their products, will all benefit from a clear regulatory
framework for CBD products.
About ONE HEMP
ONE HEMP's founding mission is to demand regulatory standards by
Congress and the FDA that treat CBD products as dietary supplements
and serve as a leading scientific resource to policymakers to
ensure consumer safety and consistency. ONE HEMP is an industry
working group comprised of leading voices and CBD market leaders.
The group has enlisted some of the world's foremost cannabinoid
researchers and toxicologists, ensuring that their approach is
firmly rooted in robust scientific research and a deep
understanding of CBD's safety profile. ONE HEMP aims to set
industry benchmarks, nurturing trust and innovation in the CBD
sector. Industry leaders that have joined ONE HEMP include -- among
others -- Charlotte's Web, Kazmira, and OBX (alphabetical
order). Taken together these leaders represent the largest
providers of CBD products. Learn more at www.onehemp.org.
To Join ONE HEMP, please contact Kelly
D. Fair at kelly.fair@dentons.com.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc., a Certified B Corporation
headquartered in Louisville,
Colorado, is the market leader in innovative hemp extract
wellness products under a family of brands that includes
Charlotte's Web™, ReCreate™, CBD Medic™, and CBD Clinic™.
Charlotte's Web whole-plant CBD extracts come in full-spectrum and
broad-spectrum options, including ReCreate™ by Charlotte's Web,
broad-spectrum CBD certified NSF for Sport®. ReCreate is the
official CBD of Major League Baseball©, Angel City Football Club
and the Premier Lacrosse League. Charlotte's Web branded premium
quality products start with proprietary hemp genetics that are
North American farm-grown using organic and regenerative
cultivation practices. The Company's hemp extracts have naturally
occurring botanical compounds including cannabidiol ("CBD"), CBC,
CBG, terpenes, flavonoids, and other beneficial compounds.
Charlotte's Web product categories include CBD oil tinctures
(liquid products) CBD gummies (sleep, calming, exercise recovery,
immunity), CBD capsules, CBD topical creams and lotions, as well as
CBD pet products for dogs. Through its substantially vertically
integrated business model, Charlotte's Web maintains stringent
control over product quality and consistency with analytic testing
from soil to shelf for quality assurance. Charlotte's Web products
are distributed to retailers and health care practitioners
throughout the U.S.A, and online
through the Company's website at
www.charlottesweb.com.
Subscribe to Charlotte's Web investor news.
© Major League Baseball trademarks and copyrights are used
with permission of Major League Baseball. Visit MLB.com.
Forward-Looking Information
Certain information provided herein constitutes
forward-looking statements or information (collectively,
"forward-looking statements") within the meaning of applicable
securities laws. Forward-looking statements are typically
identified by words such as "may", "will", "should", "could",
"anticipate", "expect", "project", "estimate", "forecast", "plan",
"intend", "target", "believe" and similar words suggesting future
outcomes or statements regarding an outlook. Forward-looking
statements are not guarantees of future performance and readers are
cautioned against placing undue reliance on forward-looking
statements. By their nature, these statements involve a variety of
assumptions, known and unknown risks and uncertainties, and other
factors which may cause actual results, levels of activity, and
achievements to differ materially from those expressed or implied
by such statements. The forward-looking statements contained in
this press release are based on certain assumptions and analysis by
management of the Company in light of its experience and perception
of historical trends, current conditions and expected future
development and other factors that it believes are appropriate and
reasonable. Specifically, this press release contains
forward-looking statements relating to, but not limited to:
regulatory developments and the impact of developments on both
consumer action and the Company's opportunities and operations;
activities relating to, and sponsorship of, legislation to advance
regulatory framework.
The material factors and assumptions used to develop the
forward-looking statements herein include, but are not limited to:
regulatory regime change and including but not limited to
those risks and uncertainties discussed under the heading "Risk
Factors" in the Company's Annual Report on Form 10-K for the year
ending December 31, 2022 and other
risk factors contained in other filings with the Securities and
Exchange Commission available on www.sec.gov and filings with
Canadian securities regulatory authorities available on
www.sedarplus.ca. The impact of any one risk, uncertainty, or
factor on a particular forward-looking statement is not
determinable with certainty as these are interdependent, and the
Company's future course of action depends on management's
assessment of all information available at the relevant
time.
Any forward-looking statement in this press release is based
only on information currently available to the Company and speaks
only as of the date on which it is made. Except as required by
applicable law, the Company assumes no obligation to publicly
update any forward-looking statement, whether as a result of new
information, future events, or otherwise. All forward-looking
statements, whether written or oral, attributable to the Company or
persons acting on the Company's behalf, are expressly qualified in
their entirety by these cautionary statements.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cbd-consumer-science-and-policy-experts-joined-one-hemp-in-dc-briefing-to-urge-congress-to-meet-the-market-where-it-is-302009064.html
SOURCE Charlotte's Web Holdings, Inc.